favourites

Defending the Bayh-Dole Act, or why governments shouldn't dictate the cost of drugs

Innovators in the U.S. must maintain their intellectual property rights if they are to provide the returns expected by current and future investors.

Nigel Rawson And John Adams, Opinion Contributors

The U.S. Food and Drug Administration (FDA) has, for the first time ever, given permission to import a number of drug classes from Canada for...

Don’t import a flawed policy from Canada. High drug prices are a made-in-America problem that require a made-in-America solution.